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Abstract
Human peritoneal mesothelial cells (HMC) contribute to
the activation and control of inflammatory processes in
the peritoneum by their potential to produce various
inflammatory mediators. The present study was de-
signed to assess the effect of glucose, the osmotic active
compound in most commercially available peritoneal
dialysis fluids, on the synthesis of the C-C chemokine
monocyte chemoattractant protein-1 (MCP-1) in cultured
HMC. The MCP-1 concentration in the cell supernatants
was determined by enzyme-linked immunosorbent as-
say and the MCP-1 mRNA expression was examined
using Northern blot analysis. Incubation of HMC with
glucose (30–120 mM) resulted in a time- and concentra-
tion-dependent increase in MCP-1 protein secretion and
mRNA expression. After 24 h the MCP-1 synthesis was
increased from 2.8 B 0.46 to 4.2 B 0.32 ng/105 cells (n =
5, p ! 0.05) in HMC treated with 60 mM glucose. In con-
trast, osmotic control media containing either the meta-
bolically inert monosaccharide mannitol or NaCl did not
influence MCP-1 production. The stimulating effect of
high glucose on MCP-1 expression in HMC was mim-
icked by activation of protein kinase C (PKC) with the
phorbol ester PMA (20 nM). Coincubation of the cells
with glucose and the specific PKC inhibitor Ro 31–8220
completely blunted glucose-mediated MCP-1 expres-
sion. In summary, our results indicate that glucose
induces MCP-1 synthesis by a PKC-dependent pathway.
Since osmotic control media did not increase MCP-1
release, it is suggested that the effect of glucose is main-
ly related to metabolism and not to hyperosmolarity.
These data may in part explain elevated steady-state lev-
els of MCP-1 found in the dialysis effluent of continuous
ambulatory peritoneal dialysis patients.
Copyright © 2001 S. Karger AG, Basel
Introduction
Mesothelial cells constitute the main cell population of
the peritoneal membrane. Besides being an active perme-
ability barrier during continuous ambulatory peritoneal
dialysis (CAPD), the mesothelium is in close proximity to
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the underlying peritoneal capillaries and has significant
potential to contribute to the activation and control of
inflammatory processes in the peritoneal cavity [1]. In
response to bacteria or proinflammatory cytokines, hu-
man peritoneal mesothelial cells (HMC) produce various
inflammatory mediators including adhesion molecules
(VCAM, ICAM) [2, 3], cytokines (interleukin (IL)-1 and
IL-6) [4, 5], and the chemokines IL-8, RANTES and
monocyte chemoattractant protein-1 (MCP-1) [6–8]. Re-
cently it has been found that also chemokine receptors are
expressed by mesothelial cells [9]. MCP-1 belongs to the
C-C chemokine family and has chemotactic activity for
mononuclear cells [10]. Although the precise cellular sig-
naling mechanisms that control neutrophilic and mono-
cytic cell infiltrate into the peritoneal cavity are not fully
understood, MCP-1 has been shown to be a potent mono-
cyte chemoattractant and activator, which leads to the
influx of monocytes in inflammatory tissue [11, 12]. In
addition, in vitro studies demonstrate that C-C and
C-X-C chemokines are involved in the migration of leu-
kocytes across mesothelium [13].
In recent studies, high levels of MCP-1 were detected
in the effluent of CAPD patients suffering from peritoni-
tis [11, 14, 15]. Since in the initial phase of peritonitis
only a small number of resident macrophages are present
in the peritoneum, it has been hypothesized that besides
macrophages also HMC account for the MCP-1 produc-
tion in the peritoneal cavity [15]. This assumption is sup-
ported by the finding that not only during episodes of
peritonitis but also in clinically stable CAPD patients high
steady-state levels of MCP-1 were found in the dialysis
effluent [11]. The underlying mechanism of this persistent
MCP-1 production during CAPD is still unclear. It has
been speculated that the dialysis solutions, to which the
HMC are exposed after each dialysate exchange, can
cause a sterile inflammatory state [16], which may be
reflected by enhanced MCP-1 synthesis in HMC.
Conventional dialysis solutions are hyperosmolar,
usually by high glucose concentrations, and have a low
pH. Previous studies indicate that the metabolic effect of
high glucose as well as its hyperosmolar concentration in
the dialysate compromise the function and metabolism of
HMC [17]. Accordingly, we recently demonstrated that
high glucose concentrations enhance the production of
prostaglandins and tissue type plasminogen activator in
HMC [18, 19]. In the present study we assessed the effect
of glucose on the expression of MCP-1 in HMC.
Materials and Methods
Materials
M199 medium and newborn calf serum were obtained from Gib-
co-BRL (Eggenstein, Germany); tissue culture plates were from Cos-
tar (Cambridge, Mass., USA). Human serum was prepared from
freshly collected blood of healthy donors and stored at –20°C.
Fibronectin from human serum and trypsin were purchased from
Boehringer Mannheim (Mannheim, Germany). Collagenase type II
was from Worthington (Freehold, N.Y., USA). D-Glucose, mannitol
and 4ß-phorbol 12-myristate 13-acetate (PMA) were purchased from
Sigma (Munich, Germany). The PKC inhibitor Ro 31–8220 was a
generous gift from Dr. G. Lawton (Hoffmann-La Roche, Welwyn
Garden City, UK) [20]. Monoclonal antibodies against cytokeratins
8 and 18 and against vimentin were a gift from Dr. G. van Muijen
(University of Nijmegen, The Netherlands).
Cell Culture Experiments
HMC were isolated from the omental tissue of consenting
patients undergoing elective surgery as described previously [21].
Cells were grown in fibronectin-coated dishes in M199 medium sup-
plemented with 25 mM Hepes (pH 7.3), 2 mM glutamine, 10% (v/v)
human serum (HS), 10% (v/v) newborn calf serum (heat-inacti-
vated), penicillin (100 IU/ml) and streptomycin (100 Ìg/ml) at 37°C
under 5% CO2/95% air atmosphere. The medium was replaced every
2–3 days. Subcultures were obtained by trypsin/EDTA treatment at a
split ratio of 1:3. Cells from omental tissue were pure mesothelial
cells as assessed by their uniform cobblestone appearance at con-
fluence, by the absence of von Willebrand factor and the uniform
positive staining for cytokeratins 8 and 18 and for vimentin [21]. For
the experiments, confluent cultures were used at the second or third
passage, and cells were always refed 24 h before the experiment with
M199, supplemented with 2% (v/v) HS, and antibiotics. All the
experiments were done with M199 + 2% HS supplemented with the
stimuli. Incubation of cells with doses of tested compounds for up to
24 h did not have any significant effect on cell viability as tested by
vital cell staining with acridine orange and ethidium bromide and by
LDH release (cell viability exceeded 95%). Conditioned media were
obtained by incubating cells in 2-cm2 dishes at 37°C for 1–24 h with
0.5 ml incubation medium containing the appropriate concentration
of the test compound or stock solvent. Conditioned media were cen-
trifuged 5 min (2,000 g) to remove cells and cellular debris, and sam-
ples were frozen at –20°C until use.
Assays
Extracellular immunoreactive MCP-1 was measured using the
Immunoassay Kit from BioSource International (USA) following the
manufacturer’s instructions. Diluted aliquots of the cell supernatants
were assayed without prior purification.
RNA Isolation and Northern Blotting
Total RNA was extracted from cells as described by Chomczynski
and Sacchi [22]. RNA samples were dissolved in H2O. The RNA
concentration in each sample was determined spectrophotometri-
cally. Equal amounts of RNA from different dishes were analyzed
for their MCP-1 and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA content by Northern blot hybridization. With
Northern blotting, RNA samples were subjected to gel electrophore-
sis in formaldehyde-agarose gels. After electrophoresis, RNA was
transferred to a Nytran membrane. Hybridization was usually per-
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Fig. 1. Effect of increasing concentrations of glucose on MCP-1 syn-
thesis in HMC. HMC were incubated with control medium (310
mosm/l), glucose, mannitol (30, 60, 90, 120 mM ) or NaCl to achieve
an osmolarity of 340–430 mosm/l. MCP-1 levels were assayed in
conditioned medium obtained after 24 h of incubation. Values are
means B SEM of 5 independent experiments. * p ! 0.05 compared
with control.
Fig. 2. Time course of MCP-1 synthesis in HMC exposed to control
medium ()) or stimulating media containing 90 mM glucose (P),
90 mM mannitol ($) or NaCl (d) producing an osmolarity of
400 mosm/l. MCP-1 levels were assayed in conditioned medium
obtained after different incubation times (1–24 h). Values are means
B SEM of 4 independent experiments. * p ! 0.05 compared with
control.
formed at 62°C with 1 ng/ml of probe labeled by random prime
labeling (Megaprime, Amersham, Germany) to approximately 2 !
108 cpm/Ìg DNA. The membranes were subsequently exposed to
Amersham Hyperfilm-MP with an intensifying screen at –80°C.
cDNA Probes
The following cDNA fragments were used as probes in the
hybridization experiments: a 0.7-kb Bam HI fragment of the mouse
JE/MCP-1 gene and a 0.8-kb Hind III fragment of the human
GAPDH gene.
Statistical Analysis
Data are given as mean B SEM. Statistical analysis was per-
formed using the Wilcoxon matched-pairs signed-ranks test for non-
parametric data and a p value ! 0.05 was considered to indicate sta-
tistically significant differences.
Results
Effect of Glucose on the MCP-1 Protein Synthesis in
HMC
To assess the effect of glucose on MCP-1 synthesis in
HMC, confluent cells were incubated with increasing con-
centrations (30–120 mM) of glucose for 24 h. The range
of the glucose concentration from 30 to 120 mM corre-
sponds to intraperitoneal concentrations found in CAPD
patients between 15 and 240 min after instillation of a
2.27% (= 126 mM) glucose-based dialysis solution. As
shown in figure 1, the addition of glucose resulted in a
dose-dependent increase in MCP-1 protein concentration
in the cell supernatants being statistically significant at a
concentration of 60 mM (control 2.8 B 0.46 vs. glucose
4.2 B 0.32 ng/105 cells, n = 5).
To further investigate whether stimulation of MCP-1
synthesis by glucose was related to hyperosmolarity or
other, possibly metabolic effects, the cells were in parallel
incubated with increasing concentrations of the metaboli-
cally inert monosaccharide mannitol or of the crystalloid
agent NaCl (fig. 1). The medium osmolarity was in-
creased by addition of mannitol or NaCl to achieve the
same osmolarity caused by glucose (the concentration of
30–120 mM glucose or mannitol corresponds to the
osmolarity of 340–430 mosm/l). As shown in figure 1,
mannitol and NaCl did not influence MCP-1 protein lev-
els. These results indicate that the enhanced MCP-1 pro-
duction is a specific effect of the high glucose medium and
is not related to changes in extracellular osmolarity.
The stimulatory effect of glucose (90 mM) was also
time-dependent. As demonstrated in figure 2, MCP-1 lev-
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Fig. 3. MCP-1 mRNA expression by HMC in response to control
medium or glucose (90 mM ). HMC were incubated for 1, 2 and 4 h in
M199 supplemented as indicated and total RNA was extracted from
cells and analyzed by Northern blot hybridization for MCP-1 and
GAPDH.
els increased continuously reaching statistically signifi-
cant differences after 24 h. Again the effect was not repro-
duced by exposure to either of the osmotic control me-
dia.
Effect of Glucose on the MCP-1 mRNA Expression in
HMC
A Northern blot analysis was performed to find out
whether the elevated MCP-1 levels in the presence of glu-
cose were related to increased MCP-1 mRNA expression.
HMC were stimulated with glucose for various time peri-
ods, and total RNA was extracted. Figure 3 shows that
glucose constantly increased MCP-1 mRNA accumula-
tion. MCP-1 mRNA levels peaked between 2 and 4 h.
MCP-1 mRNA levels also slightly increased in unstimu-
lated cells, which may be caused by mechanical irritation
of medium exchange. Nevertheless, cells incubated with
high glucose medium constantly displayed higher steady-
state mRNA levels for MCP-1 when compared with the
corresponding control.
Role of Protein Kinase C (PKC) in Glucose-Induced
MCP-1 Synthesis
Since activation of PKC by high glucose conditions has
been observed in different cell types [23], we further
investigated whether the effect of glucose on MCP-1
expression is mediated by a PKC-sensitive pathway in
HMC. As shown in figure 4a, exposing cultured HMC to
PMA, an active phorbol ester, at a concentration of 20 nM
for 24 h resulted in an almost 2-fold increase in MCP-1
Fig. 4. a Inhibition of glucose (90 mM )- or PMA (20 nM )-induced
MCP-1 synthesis by the PKC inhibitor Ro 31–8220 (Ro: Ro 31–
8220 (3 ÌM ); wo/Ro: without Ro 31–8220). MCP-1 levels were
assayed in conditioned medium obtained after 24 h incubation of
HMC in media supplemented as indicated. Values are means B
SEM of 4 independent experiments. * p ! 0.05 compared to control
conditions (wo/Ro). ** p ! 0.05 compared to glucose or PMA. b Inhi-
bition of glucose (90 mM )- or PMA (20 nM )-induced MCP-1 mRNA
expression by the PKC inhibitor Ro 31–8220 (Ro: Ro 31–8220
(3 ÌM )). HMC were incubated for 2 h in media supplemented as
indicated and total RNA was extracted from cells and analyzed by
Northern blot hybridization for MCP-1 and GAPDH.
synthesis, which is comparable to the effect of glucose.
Similar effects of PMA were observed on the expression
of the MCP-1 gene (fig. 4b). Coincubation with the spe-
cific PKC inhibitor Ro 31–8220 completely inhibited the
stimulatory effect of PMA as well as the stimulatory effect
of glucose on MCP-1 synthesis (fig. 4a). According to that,
Ro 31–8220 completely abrogated the PMA and glucose-
induced increase in MCP-1 mRNA levels. These data
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indicate that activation of PKC is required to transduce
the effect of glucose on MCP-1 gene expression and pro-
tein synthesis.
Discussion
Mesothelial cells are known to actively participate in
peritoneal or pleural inflammation by the release of che-
mokines, including IL-8, RANTES and the chemoattrac-
tant protein MCP-1 [1, 6]. MCP-1 is produced by HMC in
response to IL-1, TNF-·, interferon-Á and LPS [6]. It has
been demonstrated in vitro and in an animal model that
MCP-1 plays a critical role in regulating the migration of
mononuclear cells across the mesothelium which takes
place in the inflammatory response during bacterial infec-
tion [11, 12]. The present study demonstrates that high
glucose upregulates the expression of MCP-1 at the
mRNA and protein levels in a concentration-dependent
manner independent of proinflammatory mediators.
Since HMC are continuously exposed to glucose during
peritoneal dialysis with most available hyperosmolar dial-
ysis solutions, these in vitro observations may also be of
relevance in vivo. In confirmation, high levels of MCP-1
have been detected in the dialysis effluent of CAPD
patients without infections as compared to the MCP-1
protein in the peritoneal fluid of healthy controls [11].
Taken together, it is indicated that high glucose concen-
trations in dialysis solutions may at least in part account
for elevated MCP-1 concentrations in the peritoneal ef-
fluent and contribute to a sterile inflammatory state. This
may explain that during CAPD a population of resident
macrophages of monocytic origin is found in the peritone-
al effluent even in the absence of inflammation, i.e. with-
out the presence of neutrophils [16]. In contrast, the che-
mokine RANTES, also a chemoattractant protein which
is produced in mesothelial cells, could not be detected in
stable effluents [11] and was not inducible by glucose in
our experiments (data not shown). Since metabolically
inert osmotic solutes – mannitol and NaCl – did not
influence MCP-1 production, our data indicate that in-
creased MCP-1 synthesis in response to glucose is me-
diated by a specific metabolic effect.
Several reports have demonstrated that high glucose
exerts its effects on cultured cells by the generation of dia-
cylglycerol which can activate PKC [23]. Thus, we have
previously shown that high glucose increases PGE2 syn-
thesis in HMC via a PKC-dependent pathway [18]. In
parallel to these observations, glucose-induced MCP-1
synthesis was also sensitive to a PKC-mediated pathway,
since the specific PKC inhibitor Ro 31–8220 completely
inhibited the stimulatory effects of glucose and PMA. In
confirmation, MCP-1 expression in response to glucose
has been found to be sensitive to the PKC signal transduc-
tion pathway in human mesangial cells [24].
In conclusion, we demonstrate that MCP-1 gene ex-
pression and protein synthesis in HMC is induced by high
glucose concentrations. Our results strongly suggest that
the effect of glucose is specific and involves activation of
PKC. Current dialysis solutions containing high glucose
concentrations may induce at least a transitory increase in
intraperitoneal MCP-1 levels which may contribute to the
influx of relatively immature macrophages into the peri-
toneal cavity of stable CAPD patients.
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